Duke Clinical Research Institute

Duke Clinical Research Institute
Name	Duke Clinical Research Institute
Established	1998
Location	Durham, North Carolina
Affiliation	Duke University School of Medicine
Director	Victor J. Dzau
Staff	1,400

Duke Clinical Research Institute is an academic clinical research organization affiliated with Duke University School of Medicine and located in Durham, North Carolina. It conducts multicenter clinical trials, observational studies, and health outcomes research in collaboration with academic centers, pharmaceutical industry partners, and governmental agencies such as the National Institutes of Health, U.S. Food and Drug Administration, and Centers for Disease Control and Prevention. The institute integrates expertise from departments including Cardiology, Oncology, Neurology, Endocrinology, and Pediatrics to advance translational science and evidence generation.

History

Founded in 1998, the institute grew out of earlier research initiatives at Duke University and the Duke University Medical Center to centralize clinical trial management and biostatistics support. Early leadership included faculty from Cardiology and Epidemiology who had worked on multicenter trials with partners such as Boston Scientific, Bristol-Myers Squibb, Pfizer, and the World Health Organization. Over time the institute expanded through grants from the National Heart, Lung, and Blood Institute, cooperative agreements with the Agency for Healthcare Research and Quality, and contracts with the European Medicines Agency. Its timeline includes major trial launches, registry developments, and growth into a global network engaging sites across North America, Europe, Asia, and Africa.

Mission and Organization

The institute’s mission aligns with the translational priorities of Duke University Health System and the School of Medicine to improve patient outcomes through rigorous trials, pragmatic studies, and patient-centered research. Organizationally, it comprises cores in Biostatistics and Data Management, Clinical Operations, Regulatory Affairs, and Health Economics and Outcomes Research. Leadership interactions include deans from the Duke University School of Medicine, chairs of Medicine and Surgery, and collaboration with institutional review boards such as those modeled on the Common Rule. Governance features partnerships with industry sponsors including Johnson & Johnson, Merck & Co., Novartis, and consortiums like the Clinical Trials Transformation Initiative.

Research Programs and Areas of Expertise

The institute’s research spans cardiovascular medicine, oncology therapeutics, infectious disease trials, and chronic disease management. Signature programs include large-scale cardiovascular studies linked to professional societies like the American College of Cardiology, stroke research coordinated with the American Heart Association, and diabetes outcomes tied to guidelines from the American Diabetes Association. Expertise encompasses randomized controlled trial design, pragmatic trial frameworks influenced by the PRECIS model, adaptive designs endorsed by regulators such as the European Medicines Agency, and registries modeled after initiatives like Get With The Guidelines. Additional areas include comparative effectiveness research funded by the Patient-Centered Outcomes Research Institute and global health trials connected to the Bill & Melinda Gates Foundation.

Clinical Trials and Operations

Operational capacity supports phase II–IV trials and complex adaptive platform trials comparable to models used in RECOVERY Trial and large cardiovascular outcomes trials run by institutions like Brigham and Women's Hospital. The institute manages site networks, electronic data capture systems inspired by standards from Health Level Seven International, and centralized monitoring approaches aligned with Good Clinical Practice. Trial portfolios have included acute coronary syndrome studies, oncology immunotherapy trials paralleling work at Memorial Sloan Kettering Cancer Center, and vaccine trials in partnership with GAVI and national ministries of health. Quality assurance leverages auditing frameworks similar to those of the Pharmaceutical Research and Manufacturers of America.

Collaborations and Partnerships

Partnerships include academic collaborators such as Johns Hopkins University, Harvard Medical School, Stanford University School of Medicine, and international centers like Karolinska Institutet. Industry collaborations span AstraZeneca, Eli Lilly and Company, Roche, and biotechnology firms. Public-sector relationships include cooperative agreements with NIH, contracts with FDA, and project work with agencies like USAID in global trials. The institute also engages with professional bodies such as the European Society of Cardiology and patient advocacy organizations including American Cancer Society and American Diabetes Association.

Education and Training

Educational offerings include fellowships, internships, and training programs for clinicians, biostatisticians, and project managers modeled on curricula from institutions such as Mayo Clinic and Cleveland Clinic. The institute provides career development awards in collaboration with NIH K-series constructs and hosts workshops drawing faculty from Columbia University Vagelos College of Physicians and Surgeons and Yale School of Medicine. Trainees gain exposure to regulatory submission processes, data science platforms similar to those used at Broad Institute, and study design methodologies promoted by CONSORT guidelines.

Notable Achievements and Impact

The institute has coordinated landmark trials influencing guidelines by the American College of Cardiology, American Heart Association, and European Society of Cardiology, and contributed evidence cited in Cochrane reviews and guideline statements from National Institute for Health and Care Excellence. Its pragmatic trials and registries have informed care pathways used at health systems such as Kaiser Permanente and policy decisions at Centers for Medicare & Medicaid Services. Recognition includes awards and citations in journals like The New England Journal of Medicine, The Lancet, Journal of the American Medical Association, and collaborative contributions to landmark studies involving investigators from Massachusetts General Hospital and University of Oxford.

Category:Medical research institutes